Back to INBX
VIKING GLOBAL INVESTORS LP → INBX
VIKING GLOBAL INVESTORS LP INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
8
Latest value
$110.9M
Q3 2026
Peak value
$271.7M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $125.3M |
| Q2 2023 | $172.4M |
| Q3 2023 | $131.2M |
| Q4 2023 | $271.7M |
| Q1 2024 | $250M |
| Q1 2026 | $96.7M |
| Q2 2026 | $106.5M |
| Q3 2026 | $110.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $110.9M | 1.11M | — | — |
| Q2 2026 | $106.5M | 1.12M | — | — |
| Q1 2026 | $96.7M | 1.44M | — | — |
| Q1 2024 | $250M | 7.15M | — | — |
| Q4 2023 | $271.7M | 7.15M | — | — |
| Q3 2023 | $131.2M | 7.15M | — | — |
| Q2 2023 | $172.4M | 6.64M | — | — |
| Q1 2023 | $125.3M | 6.64M | — | — |
Other funds holding INBX
$129.3M
$126.4M
$120M
$115.9M
$114.8M
$109.7M